Shedding; towards a new paradigm of syndecan function in cancer
Authors:
- So-Joong ChoiSCSo-Joong Choi
- Ha-Won LeeHLHa-Won Lee
- Jung-Ran ChoiJCJung-Ran Choi
- Eok-Soo OhEOEok-Soo Oh
Open Access
- 31 May 2010
- journal article
- Published by Korean Society for Biochemistry and Molecular Biology - BMB Reports in BMB Reports
- Vol. 43 (5) , 305-310
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Receptor Activator of NF-κB (RANK) Ligand Induces Ectodomain Shedding of RANK in Murine RAW264.7 MacrophagesThe Journal of Immunology, 2010
- Regulation of CD40L (CD154) and CD62P (p-selectin) Surface Expression upon GPIIb-IIIa Blockade of Platelets from Stable Coronary Artery Disease PatientsThrombosis Research, 2010
- Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer’s diseaseCellular and Molecular Life Sciences, 2009
- Receptor for Advanced Glycation End Products Is Subjected to Protein Ectodomain Shedding by MetalloproteinasesJournal of Biological Chemistry, 2008
- A soluble form of the receptor for advanced glycation endproducts (RAGE) is produced by proteolytic cleavage of the membrane‐bound form by the sheddase a disintegrin and metalloprotease 10 (ADAM10)The FASEB Journal, 2008
- The Ectodomain Shedding of E-cadherin by ADAM15 Supports ErbB Receptor ActivationJournal of Biological Chemistry, 2008
- Cellular roles of ADAM12 in health and diseaseThe International Journal of Biochemistry & Cell Biology, 2008
- ADAM metalloproteases and EGFR signallingBreast Cancer Research, 2003
- TACE/ADAM17 Processing of EGFR Ligands Indicates a Role as a Physiological ConvertaseAnnals of the New York Academy of Sciences, 2003
- Ectodomain shedding of TGF‐α and other transmembrane proteins is induced by receptor tyrosine kinase activation and MAP kinase signaling cascadesThe EMBO Journal, 1999